位置:首页 > 产品库 > 重组低密度脂蛋白受体的诱导降解蛋白
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
重组低密度脂蛋白受体的诱导降解蛋白
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。

Recombinant MYLIP
Recombinant myosin regulatory light chain interacting protein
基因名:

MYLIP


产品别名:

IDOL; MIR; MYLIP; myosin regulatory light chain interacting protein; myosin regulatory light chain interacting protein; E3 ubiquitin-protein ligase MYLIP; E3 ubiquitin ligase-inducible degrader of the low density lipoprotein receptor; RING-type E3 ubiquitin transferase MYLIP; band 4.1 superfamily member BZF1; cellular modulator of immune recognition (c-MIR); inducible degrader of the LDL-receptor; 低密度脂蛋白受体的诱导降解蛋白;


背景信息:
E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of myosin regulatory light chain (MRLC), LDLR, VLDLR and LRP8. Proteasomal degradation of MRLC leads to inhibit neurite outgrowth in presence of NGF by counteracting the stabilization of MRLC by saposin-like protein (CNPY2/MSAP) and reducing CNPY2-stimulated neurite outgrowth. Acts as a sterol-dependent inhibitor of cellular cholesterol uptake by mediating ubiquitination and subsequent degradation of LDLR.
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025